Scopus BioPharma Inc (SCPS)
0.0011
0.00 (0.00%)
USD |
OTCM |
May 17, 14:00
Scopus BioPharma Cash and Short Term Investments (Quarterly): 0.3621M for June 30, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | 0.3621M |
| March 31, 2023 | 1.402M |
| December 31, 2022 | 0.1246M |
| September 30, 2022 | 0.3108M |
| June 30, 2022 | 1.156M |
| March 31, 2022 | 3.975M |
| December 31, 2021 | 7.943M |
| September 30, 2021 | 3.632M |
| Date | Value |
|---|---|
| June 30, 2021 | 6.261M |
| March 31, 2021 | 8.256M |
| December 31, 2020 | 1.832M |
| September 30, 2020 | 0.4206M |
| December 31, 2019 | 0.0367M |
| June 30, 2019 | 0.8694M |
| March 31, 2019 | 0.5465M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0367M
Minimum
Dec 2019
8.256M
Maximum
Mar 2021
2.613M
Average
1.279M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 1.823M |
| Palatin Technologies Inc | 10.01M |
| iBio Inc | 2.788M |
| Theriva Biologics Inc | 18.26M |
| Oragenics Inc | 3.484M |